These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2662524

  • 1. Preservation of renal function using OKT3 in liver transplant patients.
    Millis JM, Baquerizo A, Saleh S, Danovitch GM, Busuttil RW.
    Transplant Proc; 1989 Jun; 21(3):3551-2. PubMed ID: 2662524
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical development of Orthoclone OKT3.
    Cosimi AB.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. OKT3 immunoprophylaxis in human liver transplantation.
    Mühlbacher F, Steininger R, Längle F, Sautner T, Gnant M, Götzinger P, Piza F, Popow T.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2253-4. PubMed ID: 2652731
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histologic response to OKT3 therapy for hepatic allograft rejection.
    Rohrer RJ, Jenkins RL, Khettry U, Benotti PN, Dodson TF, Karlson CG, Georgi BA, Monaco AP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation.
    Millis JM, McDiarmid SV, Hiatt JR, Brems JJ, Colonna JO, Klein AS, Ashizawa T, Hart J, Lewin K, Goldstein LI.
    Transplantation; 1989 Jan; 47(1):82-8. PubMed ID: 2521409
    [Abstract] [Full Text] [Related]

  • 12. Cadaveric renal transplantation in the cyclosporine and OKT3 eras.
    Stratta RJ, D'Alessandro AM, Hoffmann RM, Sollinger HW, Kalayoglu M, Lorentzen DF, Pirsch JD, Belzer FO.
    Surgery; 1988 Oct; 104(4):606-15. PubMed ID: 3051470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effects of prophylactic OKT3 in cadaver kidney transplantation: comparison with cyclosporin A in a single-center prospective randomized study.
    Goldman M, Abramowicz D, De Pauw L, Marécaux G, Vanderwinden JM, Kinnaert P, Vereerstraeten P.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1046-7. PubMed ID: 1899148
    [No Abstract] [Full Text] [Related]

  • 15. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.
    Thistlethwaite JR, Haag BW, Gaber AO, Stuart JK, Aronson AJ, Mayes JT, Lloyd DM, Stuart FP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1901-4. PubMed ID: 3103294
    [No Abstract] [Full Text] [Related]

  • 16. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
    Hamilton G, Mühlbacher F, Steininger R, Havel M, Kreuzer S, Laengle F, Piza F.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
    Goldstein G, Norman DJ, Shield CF, Kreis H, Burdick J, Flye MW, Rivolta E, Starzl T, Monaco A.
    Prog Clin Biol Res; 1986 Feb; 224():239-49. PubMed ID: 3540993
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.